Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Lymphoma

Here you will find summaries of a selection of ongoing clinical trials on lymphoma.

Trials with medicinal products

BIANCA (B-NHL)  Clinical study with tisagenlecleucel in children and adolescents with B-cell non-Hodgkin lymphoma (B-NHL) - closed for inclusion

CRISP (tumors with ALK/MET/ROS1 abnormalities)  Clinical study of the safety and efficacy of the drug crizotinib in children, either alone or in combination with other drugs - open for inclusion

Daratumumab ALL2005 – Delphinus ( ALL/LL) Clinical study of the combination of daratumumab with standard chemotherapy for the treatment of children and young adults with relapsed acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) - open for inclusion

Durvalumab D419EC00001 (hematological/solid tumors)  Clinical study to evaluate the safety, tolerability and efficacy of durvalumab, or durvalumab in combination with tremelimumab, in young patients with advanced solid tumors or hematological malignancies - open for inclusion

ESMART (different tumor types)  Clinical study in children with cancer into the safety and efficacy of drugs matching a specific DNA alteration in the tumor - open for inclusion

Inotuzumab ITCC-059 (ALL/B-cell leukemia/lymphoma) Clinical study of the safety and efficacy of the drug Inotuzumab Ozogamicin (InO) in children with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) or other CD22-positive malignancies - open for inclusion

Nivolumab CA 209-744 (Hodgkin-lymphoma)  Clinical study of the safety, tolerability and efficacy of the drug nivolumab in combination with brentuximab vedotin in children with classic Hodgkin lymphoma - closed for inclusion

Ponatinib INCB084344 (leukemia/solid tumors)  Clinical study of the safety and efficacy of ponatinib for the treatment of different types of leukemia or solid tumors in children - open for inclusion

Venetoclax M13-833 (hematologic/solid tumors) Clinical study of the safety and efficacy of the drug venetoclax in children and young adults - open for inclusion


Other trials

Breath analysis (hemato-oncological disease)A clinical pilot study of exhaled breath as an approach in the diagnostic work-up for an invasive fungal infection in the lungs of children with an impaired immune system - open for inclusion

NHL-IgA study (B-NHL)  Clinical study of the activity of IgA therapy (antibody therapy) in the laboratory, using blood from children and teenagers with B-cell non-Hodgkin lymphoma (B-NHL) - open for inclusion

PINOCCHIO (multiple types of cancer)Clinical study in children on the metabolism, distribution and excretion of chemotherapy in the body, also called pharmacokinetics - open for inclusion

VIKinG (AML & Burkitt lymphoma)  Clinical study of the gut microbiota as predictor for bloodstream infections in children with cancer - open for inclusion